9th Cancer Diagnostics & Treatment Conference

Theme: Advancement of new techniques and toils in cancer diagnostics

Event Date & Time

Event Location

FRANKFURT , GERMANY

18 years of lifescience communication

Performers / Professionals From Around The Globe

Conference Speaker

Jennifer Wu

Hollings Cancer Center-Medical University of South Carolina
USA

Conference Speaker

Lixin Rui

University of Wisconsin-Madison
USA

Conference Speaker

Lei Xiao

Innovative Cellular Therapeutics
China

Conference Speaker

Steven L Warner

Tolero Pharmaceuticals, Inc
USA

Conference Speaker

Cynthia Bamdad

Minerva Biotechnologies
USA

Conference Speaker

Alain Charest

Harvard Medical School
USA

Conference Speaker

Alvaro Macieira-Coelho

French National Institute of Health
France

Conference Speaker

Anupam Bishayee

Larkin Health Sciences Institute College of Pharmacy
USA

Tracks & Key Topics

cancer diagnostics 2019

About The Conference

Euroscion extends its heartfelt welcome to Cancer diagnostics Conference ’that will be held in Frankfurt, Germany during November 11-12 , 2019. The conference will be organised around the theme ‘Advancement of new techniques and toils in cancer diagnostics’.

Cancer Diagnostics 2019 is the premier event that brings together a unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists, industrialists and entrepreneurs meet.             

Cancer Diagnostics 2019 conference will be organized by Euroscion which is comprised of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse fields of Medical, Pharmaceutical, Clinical, Engineering, Science, Technology and Business. Cancer diagnostics 2019 deals with study of basic researches in the field of cancer & oncology. It involves identifying causes and to develop strategies for diagnosis, prevention, treatment and cure for this dreadful disease.

We look forward to an exciting 2-day scientific event, business meeting, trade fair and exhibition in the alluring city of Frankfurt, Germany.

Why to attend Cancer Diagnostics 2019?

Cancer Diagnostics 2019 is the main event that brings together a unique and international experts, scientists and decision makers both from academia and industry across the world to exchange their knowledge, expertise and research innovations in the arena of cancer treatment. This pinnacle brings together the senior level experts with a perfect blend for multidisciplinary collaboration between innovators, scientists, academicians from all over the world working in the different field of Cancer & Oncology Research

Euroscicon are corporate members of the following organisations

  • Royal Society of Biology
  • IBMS
  • British Society for Immunology
  • Rare Care UK

Opportunities for Conference Attendees

For Researchers &Faculty

  • Speaker Presentations
  • Poster Display
  • Symposium hosting
  • Workshop organizing

For Universities, Associations & Societies:

  • Association Partnering
  • Collaboration proposals
  • Academic Partnering
  • Group Participation

For Students & Research Scholars:

  • Poster Competition (Winner will get Best Poster Award)
  • Young Researcher Forum (YRF Award to the best presenter)
  • Student Attendee
  • Group registrations

For Business Delegates:

  • Speaker Presentations
  • Symposium hosting
  • Book Launch event
  • Networking opportunities
  • Audience participation

For Companies:

  • Exhibitor and Vendor booths
  • Sponsorships opportunities
  • Product launch
  • Workshop organizing
  • Scientific Partnering
  • Marketing and Networking with clients

 

Target Audience

This unique international conference provides a platform for researchers and decision makers in Cancer Diagnostics 2019 to present their latest findings.

Cancer Diagnostics 2019 welcomes

  • Oncologists

  • Cancer  Researchers

  • Clinical Researchers

  • Gynecologists

  • Radiologists

  • Pathologists

  • Immunologist

  • Scientists

  • Students

  • Young research

  • Faculty

  • Cancer Associations and Societies

  • Business Entrepreneurs

  • Training Institutes

  • Pharmaceutical Companies

  • Medical Devices Companies

  • Oncologists

  • Cancer  Researchers

  • Clinical Researchers

  • Gynecologists

  • Radiologists

  • Pathologists

  • Immunologist

  • Scientists

  • Students

  • Young research

  • Faculty

  • Cancer Associations and Societies

  • Business Entrepreneurs

  • Training Institutes

  • Pharmaceutical Companies

  • Medical Devices Companies

 

Sessions & Tracks

 Cancer Diagnostics Tools, Technologies and Procedures

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. We use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan.

Cancer Radiology

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiotherapy/radiation therapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Nuclear medicine is a branch of medicine that uses radiation to provide information about the functioning of a person's specific organs or to treat disease. Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues.

 Cancer Biomarker

 A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.

Cancer & Biopsies

A biopsy is the removal of a small amount of tissue for examination under a microscope. Other tests can suggest that cancer is present, but only a biopsy can make a definite diagnosis. Sometimes, a biopsy may be performed with the help of an imaging test, such as an ultrasound, CT scan, or MRI (see below). Occasionally, surgery may be needed to get a tissue sample. The type of biopsy you receive depends on where the possible tumor is located

Cancer Nanotechnology

Research on nanotechnology cancer therapy extends beyond drug delivery into the creation of new therapeutics available only through use of nanomaterial properties. Although small compared to cells, nanoparticles are large enough to encapsulate many small molecule compounds, which can be of multiple types. At the same time, the relatively large surface area of nanoparticle can be functionalized with ligands, including small molecules, DNA or RNA strands, peptides, aptamers or antibodies. These ligands can be used for therapeutic effect or to direct nanoparticle fate in vivo. These properties enable combination drug delivery, multi-modality treatment and combined therapeutic and diagnostic, known as “theranostic,” action. The physical properties of nanoparticles, such as energy absorption and re-radiation, can also be used to disrupt diseased tissue, as in laser ablation and hyperthermia applications

Clinical Cancer research

Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment.

Cancer Vaccines and Therapeutics

Cancer Vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines. Therapeutic vaccines represent a viable option for active immunotherapy of cancers that aim to treat late stage disease by using a patient's own immune system. The promising results from clinical trials recently led to the approval of the first therapeutic cancer vaccine by the U.S. Food and Drug Administration.

Predictive Cancer Biomarkers

Predictive cancer biomarkers hold the promise of early cancer detection, personalized treatment, and accurate patient monitoring. Cambridge Healthtech Institute’s Ninth Annual Predictive Cancer Biomarkers symposium will focus on current research regarding tumor pathways and biomarker discovery, the progress toward clinical applications such as early detection and therapy monitoring, and case studies focusing on clinical utility and actionability

Cancer Immunotherapy and Types

Immunotherapy  is treatment that uses your body's own immune system to help          fight cancer. Get information about the different types of immunotherapy and the    types of cancer they are used to treat

  • Monoclonal antibodies: which are drugs that are designed to bind to specific targets in the body. They can cause an immune response that destroys cancer cells
  • Adoptive cell transfer: which is a treatment that attempts to boost the natural ability of your T cells to fight cancer? T cells are a type of white blood cell and part of the immune system. Researchers take T cells from the tumor. They then isolate the T cells that are most active against your cancer or modify the genes in them to make them better able to find and destroy your cancer cells.
  • Cytokines: which are proteins that are made by your body’s cells. They play important roles in the body’s normal immune responses and also in the immune system’s ability to respond to cancer. The two main types of cytokines used to treat cancer are called interferons and interleukins.
  • Treatment Vaccines: which work against cancer by boosting your immune system’s response to cancer cells. Treatment vaccines are different from the ones that help prevent disease.

Cancer Treatment and Therapies

Cancer is treated in several ways, depending on each person's medical condition and type of cancer. Common treatments involve chemotherapy and radiation therapy. Other treatments include surgery and biological therapies

Cancer Genomics and Epigenetics

The fundamental goal of Genomics and Epigenetics Division is to understand genome biology and its impact on disease. Genomics is the study of information that is encoded within the full DNA sequence complement of an organism. Epigenetics is the study of how DNA is organised and regulated in the cell to promote a stably heritable phenotype without alterations in the DNA sequence

Cancer Diagnostics Market

Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring the demand for screening tools across the world. In addition, rising awareness and supportive government initiatives are some additional factors that are anticipated to boost the growth of the sector during the forecast period

Recent Diagnostics Technologies

A thorough and accurate cancer diagnosis is the first step in developing an individualized cancer treatment plan. When you first visit one of our hospitals, we will perform a complete array of diagnostic tests to accurately confirm your diagnosis and plan your individualized treatment.

Cancer Clinical Trails

As successful as researchers have been in using nanotechnology to address and solve many important questions in the laboratory, the ultimate measure of the field’s success lies in the translation of research discoveries to the clinic. Currently, multiple nanotechnology-enabled diagnostic and therapeutic agents are in clinical trials, and many more are nearing that goal.

 

 

 

 

 

Market Analysis

Importance & Scope

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. And only a global search for answers will help us get to grips with this disease. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

Cancer Diagnostics 2019 will also explore the new ideas and concepts on global scale and the topics Cancer Biology & Genetics, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, 

Glance at the Market

The advancements & cancer care in the cancer treatments is accelerating. The recent report studies on the global cancer diagnostics market for the forecast period of 2015 to 2020. This market is expected to reach $13.1 Billion by 2020 from $7.1 Billion in 2015, and is poised to grow at a CAGR of 12.9% during the forecast period. The global cancer diagnostics market is beholding a rapid transformation owing to several technological advancements in diagnostic field.

 

 

The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound annual growth rate (CAGR) of 1.3% for the period 2014-2019. Global revenue for vaccine was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2018 at a compound annual growth rate of 5.3%.

The global cancer diagnostics market is segmented based on technology, application, and region .Based on region, the market is divided into North America, Europe, Asia, and Rest of the World. Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa.

 

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!